Total Return Level Chart

View Total Return Level for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 2004. Start Trial.
Date Value
August 21, 2026 29.50
August 20, 2026 29.04
August 19, 2026 30.21
August 18, 2026 30.18
August 17, 2026 29.01
August 14, 2026 28.24
August 13, 2026 28.38
August 12, 2026 29.45
August 11, 2026 29.41
August 10, 2026 29.39
August 07, 2026 29.21
August 06, 2026 28.45
August 05, 2026 28.80
August 04, 2026 27.15
August 03, 2026 25.61
July 31, 2026 25.87
July 30, 2026 26.55
July 29, 2026 26.34
July 28, 2026 26.01
July 27, 2026 25.39
July 24, 2026 24.84
July 23, 2026 24.83
July 22, 2026 24.96
July 21, 2026 25.43
July 20, 2026 25.09
Date Value
July 17, 2026 25.60
July 16, 2026 25.63
July 15, 2026 25.92
July 14, 2026 25.49
July 13, 2026 25.50
July 10, 2026 26.22
July 09, 2026 26.41
July 08, 2026 26.00
July 07, 2026 26.20
July 06, 2026 25.77
July 02, 2026 25.97
July 01, 2026 25.20
June 30, 2026 25.30
June 29, 2026 25.20
June 26, 2026 25.32
June 25, 2026 23.72
June 24, 2026 23.36
June 23, 2026 22.60
June 22, 2026 22.09
June 18, 2026 21.62
June 17, 2026 21.60
June 16, 2026 20.94
June 15, 2026 21.26
June 12, 2026 21.09
June 11, 2026 21.39

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Incyte Corp. 127.81
Agios Pharmaceuticals, Inc. 33.09
Biogen, Inc. 216.78
Insmed, Inc. 125.77
Vertex Pharmaceuticals, Inc. 548.05